Chimene Kesserwan

2.1k total citations
24 papers, 661 citations indexed

About

Chimene Kesserwan is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Chimene Kesserwan has authored 24 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Chimene Kesserwan's work include Virus-based gene therapy research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). Chimene Kesserwan is often cited by papers focused on Virus-based gene therapy research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer-related Molecular Pathways (5 papers). Chimene Kesserwan collaborates with scholars based in United States, Canada and France. Chimene Kesserwan's co-authors include Kim E. Nichols, Jessica M. Valdez, Robert Sokolic, Fabio Candotti, Gang Wu, Emília M. Pinto, Michael R. Clay, Brent A. Orr, John Easton and Lainie Friedman Ross and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Chimene Kesserwan

24 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chimene Kesserwan United States 14 240 224 179 153 118 24 661
Tim Ripperger Germany 15 341 1.4× 259 1.2× 135 0.8× 125 0.8× 215 1.8× 46 756
Javier Suela Spain 13 268 1.1× 145 0.6× 61 0.3× 158 1.0× 102 0.9× 31 539
Sarah A. Bannon United States 14 166 0.7× 180 0.8× 285 1.6× 263 1.7× 155 1.3× 33 743
Stéphanie Struski France 16 264 1.1× 106 0.5× 112 0.6× 171 1.1× 84 0.7× 30 596
Joe Wiemels United States 8 351 1.5× 69 0.3× 150 0.8× 232 1.5× 152 1.3× 10 871
VM Santana United States 9 185 0.8× 225 1.0× 310 1.7× 240 1.6× 86 0.7× 11 674
Oluwatoyin Shonukan United States 10 355 1.5× 76 0.3× 286 1.6× 266 1.7× 42 0.4× 18 683
Michel Zwaan Netherlands 8 320 1.3× 87 0.4× 153 0.9× 335 2.2× 102 0.9× 19 715
Barbara Crescenzi Italy 18 344 1.4× 134 0.6× 207 1.2× 476 3.1× 67 0.6× 55 1.0k
Sachiyo Nishida Japan 15 247 1.0× 289 1.3× 114 0.6× 319 2.1× 45 0.4× 47 773

Countries citing papers authored by Chimene Kesserwan

Since Specialization
Citations

This map shows the geographic impact of Chimene Kesserwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chimene Kesserwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chimene Kesserwan more than expected).

Fields of papers citing papers by Chimene Kesserwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chimene Kesserwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chimene Kesserwan. The network helps show where Chimene Kesserwan may publish in the future.

Co-authorship network of co-authors of Chimene Kesserwan

This figure shows the co-authorship network connecting the top 25 collaborators of Chimene Kesserwan. A scholar is included among the top collaborators of Chimene Kesserwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chimene Kesserwan. Chimene Kesserwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nair, Nishanth Ulhas, Qun Jiang, Jun S. Wei, et al.. (2023). Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. Cell Reports Medicine. 4(2). 100938–100938. 11 indexed citations
2.
Simon, Nicholas I., Scot A. Niglio, Lisa Ley, et al.. (2023). A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.. Journal of Clinical Oncology. 41(16_suppl). TPS4607–TPS4607. 3 indexed citations
3.
Andrade, Kelvin C. de, Chimene Kesserwan, James J. Manfredi, et al.. (2022). The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute. Cell Death and Differentiation. 29(5). 1071–1073. 80 indexed citations
4.
Yu, Guangyang, Ying Pang, Chimene Kesserwan, et al.. (2021). Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas. Cancers. 13(23). 6092–6092. 22 indexed citations
5.
Gamble, Lauren A., Grace‐Ann Fasaye, Chimene Kesserwan, et al.. (2021). Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk. JAMA Surgery. 157(1). 18–18. 20 indexed citations
6.
7.
Orr, Brent A., Michael R. Clay, Emília M. Pinto, & Chimene Kesserwan. (2019). An update on the central nervous system manifestations of Li–Fraumeni syndrome. Acta Neuropathologica. 139(4). 669–687. 42 indexed citations
8.
Quinn, Emily A., Jamie L. Maciaszek, Emília M. Pinto, et al.. (2019). From uncertainty to pathogenicity: clinical and functional interrogation of a rare TP53 in-frame deletion. Molecular Case Studies. 5(4). a003921–a003921. 4 indexed citations
9.
Wang, Zhaoming, Qi Liu, Carmen L. Wilson, et al.. (2018). Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE). Clinical Cancer Research. 24(24). 6230–6235. 18 indexed citations
10.
Walsh, Michael F., Deborah Ritter, Chimene Kesserwan, et al.. (2018). Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes. Human Mutation. 39(11). 1542–1552. 27 indexed citations
11.
Kesserwan, Chimene, Emily A. Quinn, Karen Wright, et al.. (2018). Anaplastic Astrocytoma in a Child With Coffin-Siris Syndrome and a Germline SMARCE1 Mutation: A Case Report. Journal of Pediatric Hematology/Oncology. 42(3). e177–e180. 3 indexed citations
12.
Johnson, Liza‐Marie, Jessica M. Valdez, Emily A. Quinn, et al.. (2017). Integrating next‐generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics. Cancer. 123(12). 2352–2359. 65 indexed citations
13.
Schwartz, Jason R., Jing Ma, Tamara Lamprecht, et al.. (2017). The genomic landscape of pediatric myelodysplastic syndromes. Nature Communications. 8(1). 1557–1557. 130 indexed citations
14.
Valdez, Jessica M., Kim E. Nichols, & Chimene Kesserwan. (2016). Li‐Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. British Journal of Haematology. 176(4). 539–552. 69 indexed citations
15.
Kesserwan, Chimene, Lainie Friedman Ross, Angela R. Bradbury, & Kim E. Nichols. (2016). The Advantages and Challenges of Testing Children for Heritable Predisposition to Cancer. American Society of Clinical Oncology Educational Book. 35(36). 251–269. 31 indexed citations
16.
Kesserwan, Chimene, Robert Sokolic, Edward W. Cowen, et al.. (2011). Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase–deficient severe combined immune deficiency. Journal of Allergy and Clinical Immunology. 129(3). 762–769.e1. 39 indexed citations
17.
Kesserwan, Chimene, Christopher J. Thoburn, Allan D. Hess, et al.. (2011). Immune Reconstitution After Nonmyeloablative, T-Cell Replete, HLA-Haploidentical BMT With Post-Transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation. 17(2). S230–S231. 3 indexed citations
18.
Sokolic, Robert, Greg M. Podsakoff, Linda Muul, et al.. (2009). Immune Reconstitution After Gene Therapy (GTx) for Adenosine Deaminase Deficient Severe Combined Immune Deficiency (ADA-SCID). Biology of Blood and Marrow Transplantation. 15(2). 27–27. 2 indexed citations
19.
Sokolic, Robert, Chimene Kesserwan, & Fabio Candotti. (2008). Recent advances in gene therapy for severe congenital immunodeficiency diseases. Current Opinion in Hematology. 15(4). 375–380. 25 indexed citations
20.
Tfayli, Arafat, et al.. (2008). Neoadjuvant therapy with celecoxib to women with early stage breast cancer.. PubMed. 55(2). 122–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Ripperger Breakdown of academic impact, for papers by Javier Suela Breakdown of academic impact, for papers by Sarah A. Bannon Breakdown of academic impact, for papers by Stéphanie Struski Breakdown of academic impact, for papers by Joe Wiemels Breakdown of academic impact, for papers by VM Santana Breakdown of academic impact, for papers by Oluwatoyin Shonukan Breakdown of academic impact, for papers by Michel Zwaan Breakdown of academic impact, for papers by Barbara Crescenzi Breakdown of academic impact, for papers by Sachiyo Nishida
Rankless by CCL
2026